Revivocell develops next dimension cell culture technology to improve research in life science and enhance drug discovery processes. We do this through our CELLBLOKS™ product.
It’s our passion to provide technology that enables researchers to replicate the interactions of multiple organs in one platform that is easy to use and can closely mimic real life scenarios, whilst reducing animal testing.
Watch our product video
We have patent applications in novel cell culture devices that enable the growth of human cell culture in multi-dimensional forms in laboratory conditions, that better replicate the environment of living tissue. Additionally, our technology enables the monitoring of cellular changes non-destructively when treated with test agents (eg., drugs, chemical, pollutants, viruses etc).
Idea of CELLBLOKS™
CELLBLOKS™ - A unique patent protected platform to enable creativity in your research. Current conventional cell culture techniques are static and self-limiting. They are grown in isolation that simply do not represent the real nature of human organ-organ interactions. See what you can do using CELLBLOKS™
Multi-organ co-culture made easy
Ever feel like you wanted to better simulate non-invasive in-vivo like conditions to further research but you have to rely on more than a century old “Petri dish” technology that simply doesn’t work or “micro-chip” approaches that complex and difficult to use.
CELLBLOKS™ provides a unique customisable platform for multi-organ physiological experiments not provided by any other product. The platform covers number of applications including:
• Pre-clinical safety and efficacy testing
• Cosmetics testing
• Life sciences research (e.g., cancer biology)
Dr. Valon LlabjaniFounder & Chief Executive Officer
PhD in Biological Sciences, Lancaster University
Dr. Valmira HotiOperations Director
BSc(Hons) in Accounting and Finance, Prishtina & PhD in Applied Statistics, LancasterUniversity
Dr. Ahtasham RazaPostdoctoral Research Associate
PhD in Biological Sciences, University of Sheffield
Anaïs MakosMaster Student
Universite de Lorraine, France
Prof. Francis L MartinPhD in Biochemical Pharmacology (London)
Chair in Biosciences, University of Central Lancashire